← Home

CT-P13 SC

1 recent articles

biotech· 디지털투데이 (DigitalToday)· 6/18/2026★ 7.0
Celltrion's Rashima Subcutaneous (CT-P13 SC) European Phase 3 Trial Part 1 Approval Expired